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Abstract
Introduction Resuscitation goals for septic shock remain 
controversial. Despite the normalization of systemic 
hemodynamic variables, tissue hypoperfusion can still persist. 
Indeed, lactate or oxygen venous saturation may be difficult to 
interpret. Our hypothesis was that a gastric intramucosal pH- 
guided resuscitation protocol might improve the outcome of 
septic shock compared with a standard approach aimed at 
normalizing systemic parameters such as cardiac index (Cl).
Methods The 130 septic-shock patients were randomized to 
two different resuscitation goals: Cl > 3.0 L/min/m2 (Cl group: 
66 patients) or intramucosal pH (pHi) > 7.32 (pHi group: 64 
patients). After correcting basic physiologic parameters, 
additional resuscitation consisting of more fluids and 
dobutamine was started if specific goals for each group had not 
been reached. Several clinical data were registered at baseline 
and during evolution. Hemodynamic data and pHi values were 
registered every 6 hours during the protocol. Primary end point 
was 28 days' mortality.
Results Both groups were comparable at baseline. The most 
frequent sources of infection were abdominal sepsis and 
pneumonia. Twenty-eight day mortality (30.3 vs. 28.1%), peak 
Therapeutic Intervention Scoring System scores (32.6 ± 6.5 vs. 
33.2 ± 4.7) and ICU length of stay (12.6 ± 8.2 vs. 16 ± 12.4 
days) were comparable. A higher proportion of patients 
exhibited values below the specific target at baseline in the pHi 
group compared with the Cl group (50% vs. 10.9%; P< 0.001). 
Of 32 patients with a pHi < 7.32 at baseline, only 7 (22%) 
normalized this parameter after resuscitation. Areas under the 
receiver operator characteristic curves to predict mortality at 
baseline, and at 24 and 48 hours were 0.55, 0.61, and 0.47, and 
0.70, 0.90, and 0.75, for Cl and pHi, respectively.
Conclusions Our study failed to demonstrate any survival 
benefit of using pHi compared with Cl as resuscitation goal in 
septic-shock patients. Nevertheless, a normalization of pHi 
within 24 hours of resuscitation is a strong signal of therapeutic 
success, and in contrast, a persistent low pHi despite treatment 
is associated with a very bad prognosis in septic-shock patients.
Introduction
The subject of the best resuscitation goal for septic shock is 
still controversial [1-5]. The early goal-directed therapy 
(EGDT) trial showed that an aggressive resuscitation protocol 
aimed at normalizing central venous oxygen saturation
(ScvO2), may improve patient outcome if started early in the 
pre-ICU setting [2]. Nevertheless, the very low ScvO2 values 
in the EGDT trial, contrast with the findings of several ICU 
studies [6-8]. Moreover, a multicentric Italian study showed no 
advantage of resuscitating against mixed venous oxygen
ACCP: American College of Chest Physicians; APACHE II: Acute Physiologic and Chronic Health Evaluation score; ATS: American Thoracic Society; 
Cl: cardiac index; EGDT: Early Goal-Directed Therapy; PAC: pulmonary artery cathéter; pCO2: partial pressure of carbon dioxide; pHi: gastric intra­
mucosal pH; ROC: receiver operator characteristic curve; SCCM: Society of Critical Care Medicine; ScvO2: central venous oxygen saturation;
SmvO2: mixed venous oxygen saturation; SOFA: Sepsis-related Organ Failure Assessment; SS: steady state; TISS: Therapeutic Intervention Scoring 
System.
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saturation (SmvO2) > 65% in critically ill patients with up to 48 
hours of shock evolution [3]. In addition, physiological interpre­
tation of lactate and central venous oxygen saturation as per­
fusion parameters may be difficult in some clinical settings, 
and both are not specific or sensitive markers of tissue hypop­
erfusion [9,10]. Moreover, it is not clear whether perfusion 
parameters are reliable if pursued late in the ICU setting [3,8].
In this context, gastric tonometry, a technique that indirectly 
assesses gastric mucosal perfusion, appears to be an attrac­
tive alternative. Low gastric intramucosal pH (pHi) is a sensi­
tive marker of splanchnic hypoperfusion and a good predictor 
of poor outcome in critically ill patients [11,12], but no study 
specifically testing its potential role as a resuscitation goal in 
septic shock has been reported.
Ten years ago, we conducted a yet-unpublished, multicenter 
randomized controlled study comparing intramucosal gastric 
pH (pHi) versus cardiac index (the latter representing macro- 
hemodynamic parameters) as therapeutic objectives in septic- 
shock patients, with the hypothesis that pHi-guided resuscita­
tion may improve survival. (Fernando Palizas, Arnaldo Dubin, 
Tomas Regueira, Alejandro Bruhn, Elias Knobel, Silvio Lazzeri, 
Natalio Baredes and Glenn Hernández, unpublished data). 
Since then, the controversial issue of the best resuscitation 
goal for septic shock has not been resolved [7,8], and there­
fore, we considered clinically relevant to present our data test­
ing an important physiologic marker of regional perfusion such 
as gastric tonometry.
Materials and methods
This study was approved by the Institutional Review Boards of 
all centers involved. All participants or their relatives signed an 
informed consent form before being enrolled in the study. The 
study was conducted from July 1998 through May 2000 in six 
closed intensive care units from Chile, Argentina and Brazil.
All adult patients fulfilling criteria for septic shock according to 
the ACCP/SCCM Consensus Conference [13] within 48 
hours of ICU admission were considered and selected if they 
were in a 12-hour time window. Exclusion criteria were: termi­
nal illness with the patient expected to die within 28 days, irre­
versible neurologic impairment, and contraindication for 
nasogastric tube placement. Randomization was done by the 
central coordinator center. All patients were initially treated to 
normalize macrohemodynamic parameters for 2 to 4 hours 
(Figure 1), especially a mean arterial pressure or 70 mm Hg or 
greater, and were randomized thereafter to a goal-directed 
therapy aimed at a gastric mucosal pHi of 7.32 or greater (pHi 
group) or a cardiac index of 3.0 L/min/m2 or more (Cl group). 
This later value was selected to prevent low systemic flow in 
this group [3]. A pulmonary artery catheter was placed in all 
patients, and additionally, patients assigned to the pHi group 
received a gastric tonometer. Measurements of pHi were 
obtained with a tonometer (TRIP NGS catheter; Tonometries, 
Inc., Worcester, MA, USA) consisting of a gas-permeable sili­
cone balloon located at the distal end of a conventional 
nasogastric tube. The silicone balloon is filled with saline, and 
carbon dioxide diffuses and equilibrates between the mucosa 
and the saline solution in the balloon to a steady state in 30 to 
90 minutes. The solution is sampled anaerobically and 
adjusted to a steady-state carbon dioxide (PCO2 SS). The 
measurement of arterial bicarbonate from a simultaneously 
obtained arterial blood gas sample allows calculation of the 
pHi by using a modified Henderson-Hasselbach equation
pHi = 6.1 + log(arterial bicarbonate) / (0.03 x tonometer pCO2 SS).
All patients received H2-receptor antagonists, and enteral 
feeding was avoided throughout the study period.
All patients received initial resuscitation aimed to normalize 
macrohemodynamic parameters and to maintain certain clini­
cal variables within physiologic limits, as shown in Figure 1. 
Additional steps (mainly fluids to reach a plateau phase in the 
Starling curve and dobutamine) were taken if the specific goal 
for each group was not achieved (Figure 1). This hemody­
namic management strategy was mandatory for the first 48 
hours of the study and recommended but not required, later. 
The PAC and tonometer were removed once the resuscitation 
goal was maintained for 24 hours and if patients were consid­
ered stable by the supervising ICU staff.
Several clinical and demographic data, including age, sex, 
cause of sepsis, admission APACHE II (Acute Physiologic and 
Chronic Health Evaluation) score, and daily SOFA (Sepsis- 
related Organ Failure Assessment) and TISS scores were reg­
istered. Patients were followed up for a maximum of 28 days. 
Hemodynamic data including cardiac index, vasoactive drugs 
dose, and pHi in the corresponding group were registered 
every 6 hours.
Statistical analysis
The primary study end point was 28-day mortality. Considering 
a two-sided type I error rate of 5%, and a power of 80%, we 
calculated that a sample size of 1 28 patients was required to 
permit the detection of a reduction in ICU mortality from 40 to 
20%. Primary analysis was carried out on an intention-to-treat 
basis; Kaplan-Meier estimates of mortality was used to 
describe the relative risk of death. Differences between the 
two groups were assessed with the use of Student's t-test and 
the chi-square test as corresponded. Receiver operator char­
acteristic (ROC) curves were determined for mortality predic­
tion with pHi and cardiac index values at different time points 
of resuscitation. Data are presented as mean ± SD. A value of 
P < 0.05 with a two-tailed test was considered statistically 
significant.
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Figure 1
Septic Shock
Admission to ICU
< 48 hours
Cardiac Index Randomization and Phi Group
Group (66) PAC inserted (64)
•-O-
Corninoli physiological objectives:
MAP > 70 mm Hg
PAOP between 14 and 16 mm Hg 
Urinary output >0.5 ml/h'kg
Arterial pH of 7.3 to 7.5
Hemoglobin >10 g/dl
Common hemodynamic protocol :
1. Volume. Saline
2. Dopamine:
Started at 4.0 pg/kg/min
Increases of 2 p^kg/min
If dose > 10 ug/'kg/min then:
3. Norepinephrine (NE) or epinephrine (E)
Started at 0.1 pg/kg/mm) and
4. Mechanical ventilation (if not in place)
JZL
Septic-shock resuscitation protocol.
Results
One-hundred thirty consecutive patients with septic shock 
were enrolled and randomly assigned to the Cl (66 patients) 
or pHi groups (64 patients). No differences between groups 
were found at baseline, except for a higher SOFA score in the 
pHi group (Table 1). The most common diagnoses were 
abdominal sepsis in 88 (68%) and pneumonia in 26 (20%) 
patients. Overall, 28-day mortality (30.3 vs. 28.1%; log-rank 
test, P = 0.98) (Figure 2), peak TISS scores (32.6 ± 6.5 vs. 
33.2 ± 4.7; P = 0.52) and ICU length of stay (12.6 ± 8.2 vs. 
16 ± 12.4 days; P = 0.07) were comparable. The cumulative 
survival curves are shown in Figure 2.
A higher proportion of patients exhibited values below the spe­
cific target at baseline in the pHi group compared with the Cl 
group (32 of 64 (50%) versus seven of 66 (10.9%); P < 
0.001). Of 32 patients with a pHi less than 7.32 at baseline, 
only seven (22%) normalized this parameter after 24 hours of 
resuscitation, and all of these patients survived. The mean val­
ues of cardiac index and pHi at different time points are shown 
in Table 2. We could not demonstrate any difference between 
Cl and pHi groups in the intensity of treatment as reflected by 
comparable peakTISS scores (32.6 ± 6.5 vs. 33.2 ± 4.7; P = 
0.52), but a trend was observed to more dobutamine use 
(31.8 vs. 48.4%; P = 0.07), with higher peak doses (8.8 ± 
10.6 vs. 13.4 ± 7.8 pg/kg/min; P= 0.1) in the pHi group. pHi 
was a better predictor of outcome than was cardiac index (Fig­
ure 3).
Discussion
Our study failed to demonstrate any difference in survival of 
septic-shock patients treated with pHi or with the cardiac 
index as a guide of hemodynamic resuscitation. Nevertheless, 
our findings confirm previous reports about the prognostic 
value of a persistent low pHi [11,1 2]. In addition, although only 
22% of patients with low admission pHi values had this param­
eter normalized after resuscitation, this fact was associated 
with a high probability of survival.
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Kaplan-Meier survival curves for both groups.
This prospective, randomized, controlled study is the first to 
evaluate the use of pHi as a resuscitation goal specifically in 
septic-shock patients. We hypothesized that these patients 
may benefit from organ perfusion-oriented resuscitation, 
because splanchnic circulation is particularly sensitive to car- 
diocirculatory changes in sepsis. Changes include a redistri­
bution of blood flow away from the mucosa, constriction of the 
villus arteriole and microcirculatory derangements [14], which 
could be associated with hypoxia and with an increase in gut 
permeability [15-18].
Why does a physiologically sound goal fail to demonstrate any 
benefit when used as a therapeutic objective? Many possible 
explanations exist. First, our study could be underpowered to 
detect a real difference, but this is unlikely when observing the 
almost superimposed Kaplan-Meier curves. Second, pHi may 
be a proper goal but only for an earlier stage of septic shock. 
This factor can strongly influence results, as demonstrated by 
the example of the positive EGDT [2] versus the negative Ital­
ian multicenter [3] trials. Both were aimed at basically the 
same resuscitation goal (central or mixed venous oxygen satu­
ration). Nevertheless, the former was used very early, in the 
pre-ICU setting, and the second, during late ICU management. 
Our study was similar in design to the Italian study, including 
patients after up to 48 hours of ICU stay. It is possible that dur­
ing this period, patients may have been exposed to prolonged 
hypoperfusion before being randomized. This may have led to 
irreversible hypoxia or multiple organ dysfunctions in some 
patients. Similarly, Gutierrez et al. [11] showed that pHi- 
guided resuscitation of critically ill patients was successful 
only in patients admitted with normal pHi. Conversely, in 
patients with intramucosal acidosis on admission, the out­
come failed to improve. This finding was ascribed to longer tis­
sue hypoxia in this group.
A third potential factor is the relative ineffectiveness of treat­
ments aimed at normalizing pHi. No study has unequivocally 
demonstrated a positive impact of specific therapies such as
Table 1
Demographic and clinical data at baseline
Cl group 
(n = 66)
pHi group
(n = 64)
P value
Age (yr) 57.4 ± 15.9 59.9 ± 15.9 0.38
Gender (male/female) 42/24 33/31 0.2
Admission APACHE II 18.5 ± 3.8 19.4 ±5.6 0.3
Admission SOFA 8.8 ± 2.7 10.6 ±3.6 < 0.05a
Sepsis source
Abdominal n/(°/o) 43 (65) 45 (70)
Pneumonia n/(°/o) 15 (23) 11 (17)
Urinary n/(°/o) 4 (6) 6(9)
Others n/(°/o) 4 (6) 2 (3)
Cl = Cardiac index; SOFA = sequential organ failure assessment 
score.
aP< 0.05 considered significant. Unpaired t test and chi-square test 
for P values.
mucosal perfusion [19,20]. Dobutamine has a relatively low 
therapeutic index, could be dangerous when used in high 
doses [4], and, in some cases, may be ineffective because 
unwanted effects (such as tachycardia or arrhythmias) pre­
clude an optimal titration. This fact could explain why both 
groups used almost comparable doses of dobutamine and 
exhibited similar cardiac indices, although more patients in the 
pHi group were below target at baseline.
Although our study did not show a survival advantage of using 
pHi-guided resuscitation in septic-shock patients, our results 
are consistent with those of the studies of Gutierrez [11] and 
Ivatury [1 2], demonstrating that patients who reach or maintain 
a normal pHi after an aggressive resuscitation have a higher 
probability of survival.
Although our results could be considered negative, it is inter­
esting to speculate about additional considerations. Except for 
the controversial EGDT trial in the early pre-ICU setting, no 
study has convincingly demonstrated an advantage of per­
fusion-oriented goals (such as lactate or SmvO2) over classic 
hemodynamic parameters as end points of resuscitation. Nev­
ertheless, many proofs exist that "normal" hemodynamic 
parameters (including mean arterial pressure, cardiac index, 
oxygen transport) can coexist with profound tissue hypoper­
fusion or microcirculatory derangements [21,22]. Therefore, 
the actual standard of care is to resuscitate septic-shock 
patients until perfusion-related parameters such as clinical 
perfusion, lactate or ScvO2/SmvO2, are normalized [1]. One 
problem with this approach is that both lactate and ScvO2 may 
be difficult to interpret in some settings (for example, liver fail­
ure, epinephrine use, or early after intubation) [8,9]. Moreover, 
tissue hypoperfusion can be present in patients with normal 
ScvO2 values [1 2]
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Figure 3
Receiver operator characteristic (ROC) curves for mortality for both groups at admission, at 24 hours, and at 48 hours.
Gastric tonometry has been shown to be well correlated with 
splanchnic perfusion in different models of shock [23-29]. In 
this context, gastric tonometry may still have a role in assess­
ing perfusion and guiding resuscitation therapy in some 
patients, in whom other markers such as lactate or ScvO2 may 
be misleading or confusing. A normalization of pHi within 24 
hours of resuscitation is a strong sign of therapeutic success, 
and in contrast, a persistent low pHi despite treatment is asso­
ciated with a very bad prognosis in septic-shock patients.
Our study was performed a decade ago. In the meantime, 
more insight has been gained into several technical and phys­
iologic limitations of gastric tonometry that have precluded its 
further technologic development or clinical acceptance. How­
ever, its physiologic rationale has been recently validated in 
several experimental studies [14-19]. Gastric tonometry has 
also undergone a number of méthodologie changes over the 
last decade, shifting from saline to automated gas tonometry, 
which incorporates the direct analysis of the intraluminal pCO2 
and pCO2 gap. One of the potential pitfalls of pHi calculation 
is that it includes arterial bicarbonate, which is a systemic 
parameter not dependent on gut perfusion. Although the use 
of a pCO2 gap instead of pHi is more physiologically sound 
[30], we do not believe that this fact would have changed our 
results. Some controversial data exist about the validity of the 
pCO2 gap as a marker of splanchnic perfusion [31-33], and it 
has not been tested as a resuscitation goal. In addition, scarce 
evidence is found about its prognostic value [34], and no clin­
ical study has demonstrated its superiority over pHi.
Our study has several limitations. First, the lack of data about 
fluid balance and SmvO2 may limit the interpretation of our 
results. Second, the use of the cardiac index as a resuscitation 
goal is questionable, because no "normal" values of Cl can be 
recommended for any given clinical condition. Instead, the 
concept of adequate or inadequate cardiac index should be 
used, according to the adequacy of flow to real O2 demand 
[35]. Nevertheless, the cardiac index has not been shown to 
be inferior to other parameters when used as resuscitation 
goal [3]. Third, in more than 60% of our septic patients, the 
sepsis was of abdominal origin, in contrast to large epidemio­
logic data that show that the lung is the predominant source 
of sepsis worldwide. Therefore, we cannot assure that our 
results would have been the same in a larger, more typical ICU 
population.
Despite these limitations, we considered it important to report 
this study because (a) the controversy about the best resusci­
tation goal for septic shock still persists; (b) other potential 
perfusion or metabolic resuscitation goals, such as ScvO2 or 
lactate, may be very difficult to interpret in some settings; (c) 
the evolution of pHi after 24 hours of resuscitation provides a 
strong prognostic signal, which could be valuable for specific 
patients; and (d) gastric tonometry has been clearly validated 
and is still widely used in the experimental setting, providing a 
strong physiological signal that probably deserves to be fur­
ther explored in the clinical arena.
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Table 2
Comparison of target values between survivors and nonsurvivors in both groups at different time points
Admission (n) 24 hours (n) 48 hours (n)
Cl group
Cardiac index
Total (66) 4.3 ± 1.1 4.05 ± 0.9 3.57 ± 1.3
Survivors (46) 4.46 ± 1.02 (46) 4.18 ± 0.7 (44) 3.56 ± 1.5 (24)
Nonsurvivors (20) 3.94 ± 1.20 (20) 3.78 ± 1.0 (20) 3.58 ± 0.9 (16)
NS NS NS
pHi group
pHi
Total (64) 7.3 ± 0.12 7.3 ± 0.1 7.28 ±0.1 2
Survivors (46) 7.32 ±0.12 (46) 7.36 ± 0.06 (46) 7.33 ±0.10 (20)
Nonsurvivors (18) 7.26 ± 0.12 (18) 7.19 ± 0.10 (18) 7.20 ± 0.13 (14)
F* NS <0.001 < 0.003
Cardiac Index
Total (64) 3.8 ± 1.1 3.8 ± 1.1 4.04 ± 1.5
Survivors (46) 3.66 ± 0.9 (46) 3.83 ± 1.1 (46) 3.47 ± 0.80 (20)
Nonsurvivors (18) 4.23 ± 1.4 (18) 3.93 ± 1.2 (18) 4.27 ± 1.29 (14)
P= NS NS NS
• A persistent low pHi despite treatment is associated 
with a very bad prognosis in septic-shock patients.
aCI of survivors i/s. nonsurvivors in the Cl group; bpHi of survivors i/s. nonsurvivors in the pHi group; °CI of survivors i/s. nonsurvivors in the pHi 
group.
A value of P < 0.05 is considered significant. Unpaired f-test for P values.
Conclusions
Our study failed to demonstrate any survival benefit of using 
the pHi compared with the cardiac index as resuscitation goal 
in septic-shock patients. Nevertheless, a normalization of pHi 
within 24 hours of resuscitation is a strong signal of therapeu­
tic success, and in contrast, a persistent low pHi despite treat­
ment is associated with a very bad prognosis in septic-shock 
patients. Future studies should evaluate a potential adjunctive 
role of tonometry-guided resuscitation at earlier stages of sep­
tic shock.
Key messages
• A resuscitation strategy aimed at normalizing pHi offers 
no survival advantage compared with cardiac index- 
guided resuscitation in septic-shock patients.
• A normalization of pHi within 24 hours of resuscitation 
is a strong signal of therapeutic success during septic- 
shock resuscitation.
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